Khalid Islam

Insider Reports History

Location
C/O Immunomedics, Inc., 300 The American Road, Morris Plains, NJ
Signature
/s/ Khalid Islam
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Khalid Islam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FENNEC PHARMACEUTICALS INC. Director Stock Option 225K $1.77M $7.88 Jun 3, 2025 Direct
Gain Therapeutics, Inc. Director Common Stock 881K $880K $1.00 Aug 9, 2024 Indirect
Gain Therapeutics, Inc. Director Common Stock 50K $49.9K $1.00 Aug 9, 2024 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock 18.2K Jan 1, 2022 Direct
Gain Therapeutics, Inc. Director Stock Option (right to buy) 15K Jun 24, 2025 Direct

Insider Reports Filed by Khalid Islam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Jun 24, 2025 1 $0 4 Jun 25, 2025 Director
FENC FENNEC PHARMACEUTICALS INC. Jun 3, 2025 1 $197K 4 Jun 4, 2025 Director
FENC FENNEC PHARMACEUTICALS INC. Aug 15, 2024 1 $140K 4 Aug 19, 2024 Director
GANX Gain Therapeutics, Inc. Aug 9, 2024 1 $49.9K 4 Aug 12, 2024 Executive Chairman, Director
GANX Gain Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 Director
FENC FENNEC PHARMACEUTICALS INC. Nov 16, 2023 8 $0 4 Nov 16, 2023 Director
GANX Gain Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
FENC FENNEC PHARMACEUTICALS INC. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
GANX Gain Therapeutics, Inc. Sep 20, 2022 1 $0 4 Sep 22, 2022 Director
FENC FENNEC PHARMACEUTICALS INC. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Mar 15, 2022 1 $0 4 Apr 19, 2022 Director
FENC FENNEC PHARMACEUTICALS INC. Jun 29, 2021 1 $0 4 Jul 1, 2021 Director